A global large-scale trial testing the use of Lecanemab provided the first evidence of a treatment to slow down the progression of Alzheimer's.
The drug Lecanemab [[Leh-canna-mab]] is now undergoing a regulatory approval process in Australia and other countries in the world, but it's exorbitant cost means few will be able to access it.
Listen to every Monday, Wednesday, Friday, and Sunday at 3 pm. Follow us on and and listen to our